KVK-Tech, Inc. has recalled 17,096 bottles of Hydrocodone Bitartrate and Homatropine Methylbromide (5 mg / 1.5 mg) tablets, a prescription medication used to treat cough. The recall was issued because the medication failed to meet approved quality standards for impurities and degradation levels. If you are taking this medication, you should consult your healthcare provider or pharmacist to discuss your treatment options and how to return the affected product.
The presence of impurities or chemical degradation beyond specified limits can make the medication less effective or potentially cause unintended side effects, although the risk level is currently classified as low.
Pharmacy refund and consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.